chr3-171612186-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002662.5(PLD1):c.2882+93A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00791 in 1,119,442 control chromosomes in the GnomAD database, including 540 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 325 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 215 hom. )
Consequence
PLD1
NM_002662.5 intron
NM_002662.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0340
Genes affected
PLD1 (HGNC:9067): (phospholipase D1) This gene encodes a phosphatidylcholine-specific phospholipase which catalyzes the hydrolysis of phosphatidylcholine in order to yield phosphatidic acid and choline. The enzyme may play a role in signal transduction and subcellular trafficking. Alternative splicing results in multiple transcript variants with both catalytic and regulatory properties. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-171612186-T-C is Benign according to our data. Variant chr3-171612186-T-C is described in ClinVar as [Benign]. Clinvar id is 1274084.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLD1 | ENST00000351298.9 | c.2882+93A>G | intron_variant | 1 | NM_002662.5 | ENSP00000342793.4 | ||||
PLD1 | ENST00000356327.9 | c.2768+93A>G | intron_variant | 1 | ENSP00000348681.5 | |||||
PLD1 | ENST00000446289.1 | c.668+93A>G | intron_variant | 1 | ENSP00000395556.1 |
Frequencies
GnomAD3 genomes AF: 0.0341 AC: 5186AN: 152036Hom.: 324 Cov.: 32
GnomAD3 genomes
AF:
AC:
5186
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00377 AC: 3651AN: 967288Hom.: 215 AF XY: 0.00327 AC XY: 1603AN XY: 490622
GnomAD4 exome
AF:
AC:
3651
AN:
967288
Hom.:
AF XY:
AC XY:
1603
AN XY:
490622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0342 AC: 5202AN: 152154Hom.: 325 Cov.: 32 AF XY: 0.0334 AC XY: 2484AN XY: 74392
GnomAD4 genome
AF:
AC:
5202
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
2484
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at